SI030011: Canagliflozin-d6 label-new C21H32O11 / 460

C21H32O11 / 460

9-trioxaundecyl) 2-acetamido-2-deoxy-α-D-galactopyranoside

N-α-Fmoc-N-γ-(2-acetamido-2-deoxy-3

a non-reducing-end fragment relevant to the glycosaminoglycan-protein linkage region (the GAG tetrasaccharide linker GlcAβ1-3Galβ1-3Galβ1-4Xyl-O-Ser includes a xylose-glucuronic acid junction)

46 / A β-D-N-acetyllactosamine (LacNAc) ligand equipped with a terminal carboxylic acid through a short butyl spacer

SI030011: Canagliflozin-d6 label-new C21H32O11 / 460C24H19D6FO5S 450. 55 Diabeties Type 2 Canagliflozin d6 (2S,3R,4R,5S,6R) 2 {3 [5 [4 Fluoro phenyl) thiophen 2 ylmethyl] 4 methyl phenyl} 6 hydroxymethyl tetrahydro pyran 3,4,5 triol d6; (1S) 1,5 Anhydro 1 C [3 [[5 (4 fluorophenyl) 2 thienyl]methyl] 4 methylphenyl] D glucitol d6; Invokana d6